Drug profile · INN
dolutegravir + abacavir + lamivudine
TRIUMEQ
dolutegravir + abacavir + lamivudine (TRIUMEQ) is an FDA-listed pharmaceutical active ingredient. Associated with ViiV Healthcare Pty Ltd.
TGA: approved
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — dolutegravir + abacavir + lamivudine
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 2
- Data quality
- 0.81
Quick answer
dolutegravir + abacavir + lamivudine (TRIUMEQ) is an FDA-listed pharmaceutical active ingredient. Associated with ViiV Healthcare Pty Ltd.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Pipeline programs
Frequently asked questions
What is dolutegravir + abacavir + lamivudine?
dolutegravir + abacavir + lamivudine (TRIUMEQ) is an FDA-listed pharmaceutical active ingredient. Associated with ViiV Healthcare Pty Ltd.
What is the brand name for dolutegravir + abacavir + lamivudine?
TRIUMEQ is a marketed brand name for dolutegravir + abacavir + lamivudine. Check FDA Drugs@FDA for the current US label holder and prescribing information.